Home / Technology / AI Investment Soars, But Value Realization Lags
AI Investment Soars, But Value Realization Lags
19 Nov
Summary
- 83% of healthcare organizations increased AI investment.
- Only 41% of organizations are scaling AI adoption.
- People and processes, not tech, limit AI value.
Research reveals that 83% of healthcare and life sciences organizations have boosted their AI investment in the past year. Despite this financial momentum, only 41% of these entities have achieved scaled or native AI adoption. This suggests that increased spending does not automatically translate into mature integration.
Key outcomes valued from AI investments in healthcare include faster delivery and improved customer experience, with innovation and risk reduction also being significant factors. Cost reduction ranks lower, indicating a strategic view of AI for growth and operational enhancement.
Measuring AI's long-term and indirect benefits remains challenging due to analytics limitations and data quality issues. Furthermore, 86% of respondents believe that people and processes, rather than technology, are the main constraints to realizing AI value. Poor data quality, resistance to change, and insufficient workforce enablement are cited as major hurdles.
The research involved 213 healthcare and life sciences executives from a broader global survey of 1,500 decision-makers across the United States, United Kingdom, Germany, Saudi Arabia, and the United Arab Emirates, conducted in July 2026.